QS Investors’s XBiotech XBIT Stock Holding History

QS Investors’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,750	Closed	-$168K	–	1249
2020 Q4	$168K	Hold	10,750	–	–	﹤0.01%	1116
2020 Q3	$206K	Sell	10,750 -49,050	-82%	-$847K	﹤0.01%	1069
2020 Q2	$820K	Buy	+59,800	New	+$840K	0.01%	784

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

QS Investors's XBIT Position: Q1 2021 in Review

QS Investors sold out of XBiotech (XBIT) in Q1 2021, closing a stake of 10,750 shares — an estimated $168K sold.

QS Investors first reported a position in XBIT in Q2 2020 and held it in 3 quarters. The position peaked at $820K in Q2 2020. 65 funds tracked by Wall St. Rank hold XBIT as of Q1 2021.

QS Investors reported no remaining XBiotech position as of Q1 2021 after selling out during the quarter.
QS Investors sold 10,750 XBiotech shares in Q1 2021, an estimated $168K.
QS Investors first reported a position in XBiotech in Q2 2020 and held it in 3 quarters.
QS Investors's XBiotech position peaked at $820K in Q2 2020.
65 funds tracked by Wall St. Rank held XBiotech as of Q1 2021.

Based on QS Investors's 13F filing for Q1 2021, filed 13 May 2021.